Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IBB NYSEARCA:IHI NYSEARCA:IXJ NYSEARCA:XBI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$169.88+0.3%$169.08$120.33▼$179.64$8.07B0.731.42 million shs823,193 shsIHIiShares U.S. Medical Devices ETF$49.17-2.4%$52.17$47.37▼$64.71$3.04B0.862.33 million shs3.91 million shsIXJiShares Global Healthcare ETF$94.15+0.1%$93.29$82.16▼$101.78$3.66B0.58280,654 shs53,164 shsXBISPDR S&P Biotech ETF$134.45+0.8%$130.44$78.06▼$139.19$8.58B0.859.28 million shs7.58 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF+0.27%+1.17%+0.51%-2.30%+38.28%IHIiShares U.S. Medical Devices ETF-2.38%-3.40%-6.73%-18.48%-20.57%IXJiShares Global Healthcare ETF+0.14%+0.70%+2.67%-6.14%+10.35%XBISPDR S&P Biotech ETF+0.82%+2.08%+1.06%+5.31%+69.55%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$169.88+0.3%$169.08$120.33▼$179.64$8.07B0.731.42 million shs823,193 shsIHIiShares U.S. Medical Devices ETF$49.17-2.4%$52.17$47.37▼$64.71$3.04B0.862.33 million shs3.91 million shsIXJiShares Global Healthcare ETF$94.15+0.1%$93.29$82.16▼$101.78$3.66B0.58280,654 shs53,164 shsXBISPDR S&P Biotech ETF$134.45+0.8%$130.44$78.06▼$139.19$8.58B0.859.28 million shs7.58 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF+0.27%+1.17%+0.51%-2.30%+38.28%IHIiShares U.S. Medical Devices ETF-2.38%-3.40%-6.73%-18.48%-20.57%IXJiShares Global Healthcare ETF+0.14%+0.70%+2.67%-6.14%+10.35%XBISPDR S&P Biotech ETF+0.82%+2.08%+1.06%+5.31%+69.55%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF 2.73Moderate Buy$169.88N/AIHIiShares U.S. Medical Devices ETF 2.67Moderate Buy$49.17N/AIXJiShares Global Healthcare ETF 2.75Moderate Buy$94.15N/AXBISPDR S&P Biotech ETF 2.74Moderate Buy$134.45N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AIHIiShares U.S. Medical Devices ETFN/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AIHIiShares U.S. Medical Devices ETFN/AN/A30.76N/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/A21.58N/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.380.22%N/AN/AN/AIHIiShares U.S. Medical Devices ETF$0.220.45%N/AN/AN/AIXJiShares Global Healthcare ETF$1.361.44%N/AN/AN/AXBISPDR S&P Biotech ETF$0.440.33%N/AN/AN/ALatest XBI, IBB, IXJ, and IHI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/16/2026IBBiShares Biotechnology ETFQuarterly$0.12180.29%3/17/20263/17/20263/20/2026(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%IHIiShares U.S. Medical Devices ETFN/AIXJiShares Global Healthcare ETFN/AXBISPDR S&P Biotech ETFN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AIHIiShares U.S. Medical Devices ETFN/AIXJiShares Global Healthcare ETFN/AXBISPDR S&P Biotech ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A47.50 millionN/AOptionableIHIiShares U.S. Medical Devices ETFN/A61.90 millionN/ANot OptionableIXJiShares Global Healthcare ETFN/A38.90 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A63.80 millionN/ANot OptionableXBI, IBB, IXJ, and IHI HeadlinesRecent News About These CompaniesVHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost1 minutes ago | finance.yahoo.comIs State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?May 27 at 7:20 AM | zacks.comBiotech Investors Are Tuning Out the MAHA ChaosMay 20, 2026 | wsj.comTrade Tracker: Joe Terranova sells the biotech ETF XBIMay 19, 2026 | msn.comIf You Hold This Healthcare ETF, You're Losing BigMay 19, 2026 | 247wallst.com2 Ways to Play the Big Pharma Patent Cliff...May 14, 2026 | marketbeat.comSPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech StrengthMay 8, 2026 | fxempire.comFWhy this biotech ETF — the IBD stock of the day — just reentered its buy zoneMay 4, 2026 | msn.comLocking in a quick gain in this biotech ETF made room for better swing trades; here's whyMay 1, 2026 | msn.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?April 30, 2026 | zacks.comIs iShares Biotechnology ETF (IBB) a Strong ETF Right Now?April 28, 2026 | zacks.comEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position NowApril 23, 2026 | 247wallst.comShould You Invest in the State Street SPDR S&P Biotech ETF (XBI)?April 22, 2026 | zacks.comXBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026April 7, 2026 | 247wallst.comThis Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.April 3, 2026 | 247wallst.comBiotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still AheadMarch 28, 2026 | 247wallst.comIs State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?March 25, 2026 | zacks.comThe Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOMMarch 17, 2026 | sharewise.comSBeyond Tech Industry: Here's how Biotech ETFs Are Riding the AI WaveMarch 16, 2026 | zacks.comXBI: Biotech M&A Has Been Hot, But Price Trends Have CooledMarch 13, 2026 | seekingalpha.comIs the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?February 24, 2026 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Norwegian Cruise Line Cuts Outlook as Headwinds BuildBy Jennifer Ryan Woods | May 5, 20262 Ways to Play the Big Pharma Patent CliffBy Nathan Reiff | May 15, 2026XBI, IBB, IXJ, and IHI Company DescriptionsiShares Biotechnology ETF NASDAQ:IBB$169.88 +0.46 (+0.27%) As of 05/27/2026 04:00 PM EasterniShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.iShares U.S. Medical Devices ETF NYSEARCA:IHI$49.17 -1.20 (-2.38%) As of 05/27/2026 04:10 PM EasternThe iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.iShares Global Healthcare ETF NYSEARCA:IXJ$94.15 +0.13 (+0.14%) As of 05/27/2026 04:10 PM EasterniShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor's Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals. The Underlying Index consists of stocks of companies in countries, including Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Japan, the Netherlands, Switzerland, the United Kingdom and the United States. The Fund's investment advisor is BlackRock Fund Advisors (BFA).SPDR S&P Biotech ETF NYSEARCA:XBI$134.45 +1.10 (+0.82%) As of 05/27/2026 04:10 PM EasternSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak Dick’s Sporting Goods Isn’t Done Winning Yet Amazon's Alexa for Shopping Strengthens an Already Strong Bull Case TeraWulf Bets on Power Infrastructure to Lead AI Build-Out Zscaler Stock Drops 30%: Why the Dip Is a Buy Opportunity Shake Shack Insiders Buy as SHAK Stock Faces More Pressure Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
